Adjuvant Chemotherapy for Stage II Colon Cancer: The Role of Molecular Markers in Choosing Therapy - Wikidata - wikimedia - TriplyDB

Adjuvant Chemotherapy for Stage II Colon Cancer: The Role of Molecular Markers in Choosing Therapy

Adjuvant Chemotherapy for Stage II Colon Cancer: The Role of Molecular Markers in Choosing Therapy

http://www.wikidata.org/entity/Q33591943

about

Ribosomal protein S27-like in colorectal cancer: a candidate for predicting prognoses.miR-1269 promotes metastasis and forms a positive feedback loop with TGF-β.AJCC Cancer Staging Manual 7th edition criteria for colon cancer: do the complex modifications improve prognostic assessment?Identification of risk factors for recurrence in high-risk stage II colon cancer Discovery of genes from feces correlated with colorectal cancer progression Impact of microsatellite status on chemotherapy for colorectal cancer patients with KRAS or BRAF mutation.The pattern of epidermal growth factor receptor variation with disease progression and aggressiveness in colorectal cancer depends on tumor location.Use of Adjuvant Chemotherapy among Stage II Colon Cancer Patients in 10 Population-Based National Program of Cancer Registries.Comparison of the eighth version of the American Joint Committee on Cancer manual to the seventh version for colorectal cancer: A retrospective review of our data

P2860

Q34796352-4CE27155-A6A6-489F-BA1D-3387A5AB5529 Q35439100-2D7E8D4B-81BA-40BB-9C02-9B01661B0F5D Q36315165-A241BF99-0579-42E6-B75E-1B8CC9156801 Q37044768-2D5E1C04-070D-471C-8EBC-9048AC23CA4E Q37406961-A6C07D98-938A-42DC-9CC6-72B12507E437 Q37581999-5D6FDFB7-0B35-4339-88C3-AB436809B889 Q42225261-3F3DB3B8-5260-4AB4-A804-B8009BBAAA85 Q47196982-336747CD-7051-4C70-B183-9E90830A33DC Q58695712-7E22F783-2B85-4054-975B-6F4693598A43

P2860

Adjuvant Chemotherapy for Stage II Colon Cancer: The Role of Molecular Markers in Choosing Therapy

http://www.wikidata.org/entity/Q33591943

description

2009 nî lūn-bûn

@nan

2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Adjuvant Chemotherapy for Stag ...... ar Markers in Choosing Therapy

@ast

Adjuvant Chemotherapy for Stag ...... ar Markers in Choosing Therapy

@en

type

label

Adjuvant Chemotherapy for Stag ...... ar Markers in Choosing Therapy

@ast

Adjuvant Chemotherapy for Stag ...... ar Markers in Choosing Therapy

@en

prefLabel

Adjuvant Chemotherapy for Stag ...... ar Markers in Choosing Therapy

@ast

Adjuvant Chemotherapy for Stag ...... ar Markers in Choosing Therapy

@en

P1433

Q33591943-5498F4C1-F014-4D89-AB3A-92497408CED7

P1476

Q33591943-7219BF81-1A48-4619-B7DD-D14245A90DD2

P2093

Q33591943-12F24CA5-AE00-4FBD-965A-D035B7802E13

Q33591943-FBB9DF56-FEE4-4CF0-9F30-901DE71692CA

P2860

Q33591943-012850F4-62A2-4DFB-A744-F61221DA57A7

Q33591943-025B7F67-19AA-488C-B9A6-537C13DCFB69

Q33591943-056079A9-1D13-45B6-A67C-96CC72F6D891

Q33591943-06F74587-F3DA-48F9-A7B8-CD18BA9CA33F

Q33591943-0C8A7BEB-02B9-44AA-AFE9-A455E2479089

Q33591943-101DAE11-CE4F-4859-A390-48CD3A8C691E

Q33591943-169E5E92-5390-4C82-857A-99392EF9968C

Q33591943-23618208-A3A0-4B96-AE66-7653AA9B866B

Q33591943-2695C9F7-4E72-43B6-A248-35452ECDC000

Q33591943-274E9E7C-69AB-4E15-AA15-7217FFACF1A3

P304

Q33591943-59517943-5AA5-45EE-BCDC-F708BD2AAEA4

P31

Q33591943-C4F54C4E-73B4-4FDF-8EA8-507881E35024

P433

Q33591943-C3D21E9E-B88B-4EF1-A7DF-26F2A816012A

P478

Q33591943-97E7C245-593C-4395-9DA1-C4E74AFFD616

P577

Q33591943-77984C56-091D-479F-BE12-56544EB69F0D

P698

Q33591943-0B6224D3-2791-4232-95F3-8B580993D298

P921

Q33591943-C18022FD-B788-4DBF-813E-EFB2772CFA88

P932

Q33591943-ABC7E28E-B2A7-4601-A76A-21C809AB184E

P1433

Gastrointestinal cancer research : GCR

P1476

Adjuvant Chemotherapy for Stag ...... ar Markers in Choosing Therapy

@en

P2093

Patrick Chun

http://www.w3.org/2001/XMLSchema#string

Zev A Wainberg

http://www.w3.org/2001/XMLSchema#string

P2860

Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer

The power and the promise of DNA methylation markers

A systematic review and meta-analysis of the relationship between chromosome 18q genotype, DCC status and colorectal cancer prognosis

ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer

Systematic review of microsatellite instability and colorectal cancer prognosis

Kirsten ras mutations in patients with colorectal cancer: the 'RASCAL II' study

Molecular predictors of survival after adjuvant chemotherapy for colon cancer

CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer

What is the evidence that tumors are angiogenesis dependent?

Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999.

P304

191-196

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2009-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20084160

http://www.w3.org/2001/XMLSchema#string

P921

P932

2806802

http://www.w3.org/2001/XMLSchema#string